Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis
Introduction Achieving efficacious and safe treatments for unstable angina pectoris (UAP) is still a challenging clinical problem. The availability of different oral Chinese patent medicines frequently poses a practical challenge to clinicians, namely, which one to choose as first-line regimen for t...
Saved in:
| Main Authors: | Jinhui Tian, Guanlin Yang, Zhen Hua, Peng Xu, Feng-Ting Zhai, Cheng-Fei Gao, Fan Zhang, Si-jia Liu, Kun Dong, Xiao-Feng Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/9/e026136.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris
by: Vidosava B. Djordjević, et al.
Published: (2011-01-01) -
Coronary Artery Fistula Presenting as Unstable Angina Pectoris in Patients with Antiphospholipid Syndrome
by: Şerafettin Demir, et al.
Published: (2013-01-01) -
Thoracic Paravertebral Block as a Component of General Anesthesia in the Surgical Treatment of Unstable Angina Pectoris
by: Yu. V. Khrenov, et al.
Published: (2009-08-01) -
Unstable angina pectoris in a young male after first dose of COVID-19 MRNAvaccine
by: Billi Kinesya, et al.
Published: (2024-07-01) -
Efficacy and safety of 11 oral preparations of single-source traditional Chinese medicines in the treatment of unstable angina pectoris: a systematic review and network meta-analysis
by: Xiuchong Li, et al.
Published: (2025-06-01)